Iowa Neonatal Screening Program protocol detects primary hypothyroidism, galactosemia, hemoglobin disorders, and congenital adrenal hyperplasia. Effective 1/1/10, the Iowa Neonatal Screening Program offers an Expanded Screening Disorders: ANALYTES SCREENED: Analytes refer to amino acids: (ARG) Arginine, (ASA) Argininosuccinic Aciduria, (CIT) Citrulline, (LEU) Leucine, (MAA) Multiple Amino Acids, (MET) Methionine, (PHE) Phenylalanine, (SA) Succinlyacetone, (TYR) Tyrosine, (VAL) Valine and acylcarnitines: LOW C0, HI C0, C3, C3-DC, C4, C4-DC, C4-OH, C5, C5:1, C5-DC, C5-OH, C6, C6-DC, C8, C10, C10:1, C14, C14:1, C16, C16-OH, C16-OH/C16, C16:1-OH, C0/C16, C18:1, C18-OH, C18:1-OH, (MAC) multiple acylcarnitines. UHL requisition form MUST have the following information completed on the form before delivery to laboratory: Collector's initials, infant's last name and first name, sex, first or repeat specimen, physician name, date and time of birth, feeding method (bottle/breast/ NPO/parenteral nutrition), mother's first and last name, mother's date of birth, date and time of collection, weight at time of collection, gestational age in weeks, transfusion within the last eight weeks and date of transfusion.